Arch JR - Search Results

1

The rat lipolytic beta-adrenoceptor: studies using novel beta-adrenoceptor agonists.

Wilson C, Wilson S, Piercy V, Sennitt MV, Arch JR. Wilson C, et al. Among authors: arch jr. Eur J Pharmacol. 1984 May 4;100(3-4):309-19. doi: 10.1016/0014-2999(84)90007-4. Eur J Pharmacol. 1984. PMID: 6145597

2

An investigation of the beta-adrenoceptor that mediates metabolic responses to the novel agonist BRL28410 in rat soleus muscle.

Challiss RA, Leighton B, Wilson S, Thurlby PL, Arch JR. Challiss RA, et al. Among authors: arch jr. Biochem Pharmacol. 1988 Mar 1;37(5):947-50. doi: 10.1016/0006-2952(88)90186-4. Biochem Pharmacol. 1988. PMID: 2830888

3

Substrate supply for thermogenesis induced by the beta-adrenoceptor agonist BRL 26830A.

Wilson S, Thurlby PL, Arch JR. Wilson S, et al. Among authors: arch jr. Can J Physiol Pharmacol. 1987 Feb;65(2):113-9. doi: 10.1139/y87-023. Can J Physiol Pharmacol. 1987. PMID: 2882828

4

Beta-adrenoceptor sensitivity of brown and white adipocytes after chronic pretreatment of rats with reserpine.

Grassby PF, Arch JR, Wilson C, Broadley KJ. Grassby PF, et al. Among authors: arch jr. Biochem Pharmacol. 1987 Jan 1;36(1):155-62. doi: 10.1016/0006-2952(87)90393-5. Biochem Pharmacol. 1987. PMID: 3026402

5

BRL 35135, a potent and selective atypical beta-adrenoceptor agonist.

Cawthorne MA, Sennitt MV, Arch JR, Smith SA. Cawthorne MA, et al. Among authors: arch jr. Am J Clin Nutr. 1992 Jan;55(1 Suppl):252S-257S. doi: 10.1093/ajcn/55.1.252s. Am J Clin Nutr. 1992. PMID: 1345889 Review.

6

Anti-hyperglycaemic action of BRL 26830, a novel beta-adrenoceptor agonist, in mice and rats.

Sennitt MV, Arch JR, Levy AL, Simson DL, Smith SA, Cawthorne MA. Sennitt MV, et al. Among authors: arch jr. Biochem Pharmacol. 1985 Apr 15;34(8):1279-85. doi: 10.1016/0006-2952(85)90506-4. Biochem Pharmacol. 1985. PMID: 2859857

7

Treatment of obesity with thermogenic beta-adrenoceptor agonists: studies on BRL 26830A in rodents.

Arch JR, Ainsworth AT, Ellis RD, Piercy V, Thody VE, Thurlby PL, Wilson C, Wilson S, Young P. Arch JR, et al. Int J Obes. 1984;8 Suppl 1:1-11. Int J Obes. 1984. PMID: 6152555

8

Atypical beta-adrenoceptor on brown adipocytes as target for anti-obesity drugs.

Arch JR, Ainsworth AT, Cawthorne MA, Piercy V, Sennitt MV, Thody VE, Wilson C, Wilson S. Arch JR, et al. Nature. 1984 May 10-16;309(5964):163-5. doi: 10.1038/309163a0. Nature. 1984. PMID: 6325935

9

Prospects for beta 3-adrenoceptor agonists in the treatment of obesity and diabetes.

Arch JR, Wilson S. Arch JR, et al. Int J Obes Relat Metab Disord. 1996 Mar;20(3):191-9. Int J Obes Relat Metab Disord. 1996. PMID: 8653138 Review.

10

The contribution of classical (beta1/2-) and atypical beta-adrenoceptors to the stimulation of human white adipocyte lipolysis and right atrial appendage contraction by novel beta3-adrenoceptor agonists of differing selectivities.

Sennitt MV, Kaumann AJ, Molenaar P, Beeley LJ, Young PW, Kelly J, Chapman H, Henson SM, Berge JM, Dean DK, Kotecha NR, Morgan HK, Rami HK, Ward RW, Thompson M, Wilson S, Smith SA, Cawthorne MA, Stock MJ, Arch JR. Sennitt MV, et al. Among authors: arch jr. J Pharmacol Exp Ther. 1998 Jun;285(3):1084-95. J Pharmacol Exp Ther. 1998. PMID: 9618411

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

141 results

Search Page

Filters